MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $57,415 | $28,534 | $21,397 |
| G&A Expenses | $10,779 | $6,777 | $3,764 |
| SG&A Expenses | $10,779 | $6,777 | $3,764 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $68,194 | $35,311 | $25,161 |
| Operating Income | -$68,194 | -$35,311 | -$25,161 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $6,272 | $2,748 | -$974 |
| Pre-Tax Income | -$61,922 | -$32,563 | -$26,135 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$61,922 | -$32,563 | -$26,135 |
| % Margin | – | – | – |
| EPS | -1.85 | -1.02 | -0.82 |
| % Growth | -81.4% | -24.4% | – |
| EPS Diluted | -1.85 | -1.02 | -0.82 |
| Weighted Avg Shares Out | 33,393 | 31,854 | 31,854 |
| Weighted Avg Shares Out Dil | 33,393 | 31,854 | 31,854 |
| Supplemental Information | – | – | – |
| Interest Income | $6,272 | $2,748 | $372 |
| Interest Expense | $0 | $0 | $374 |
| Depreciation & Amortization | $244 | $157 | $56 |
| EBITDA | -$67,950 | -$35,154 | -$25,705 |
| % Margin | – | – | – |